The Enterprise Value as of December 2025 (TTM) for Vicapsys Life Sciences, Inc. (VICP) is 49.13M

According to Vicapsys Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 49.13M. This represents a change of -18.54% compared to the average of 60.31M of the last 4 quarters.

Vicapsys Life Sciences, Inc. (VICP) Historical Enterprise Value (quarterly & annually)

How has VICP Enterprise Value performed in the past?

The mean historical Enterprise Value of Vicapsys Life Sciences, Inc. over the last ten years is 13.39M. The current 49.13M Enterprise Value has changed 36.60% with respect to the historical average. Over the past ten years (40 quarters), VICP's Enterprise Value was at its highest in in the March 2025 quarter at 63.18M. The Enterprise Value was at its lowest in in the March 2009 quarter at 0.

Vicapsys Life Sciences, Inc. (VICP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vicapsys Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vicapsys Life Sciences, Inc. (VICP) Average Enterprise Value

How has VICP Enterprise Value performed in the past?

The current Enterprise Value of Vicapsys Life Sciences, Inc. (VICP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vicapsys Life Sciences, Inc. (VICP) Enterprise Value vs. Peers

How is VICP’s Enterprise Value compared to its peers?

Vicapsys Life Sciences, Inc.’s Enterprise Value is less than Calliditas Therapeutics AB (publ) (11.24B), greater than ZIVO Bioscience, Inc. (39.26M), greater than Relief Therapeutics Holding AG (24.49M), less than Helix BioPharma Corp. (178.01M), less than Arch Biopartners Inc. (85.56M), less than Amplia Therapeutics Limited (53.28M), greater than PsyBio Therapeutics Corp. (135.91K), greater than Relief Therapeutics Holding AG (24.49M), less than Oncotelic Therapeutics, Inc. (57.10M), less than Sona Nanotech Inc. (58.46M),

Build a custom stock screener for Vicapsys Life Sciences, Inc. (VICP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vicapsys Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vicapsys Life Sciences, Inc. (VICP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vicapsys Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.